Annual Working Capital
$161.29 M
-$32.09 M-16.60%
December 31, 2024
Summary
- As of March 5, 2025, PMVP annual working capital is $161.29 million, with the most recent change of -$32.09 million (-16.60%) on December 31, 2024.
- During the last 3 years, PMVP annual working capital has fallen by -$127.78 million (-44.20%).
- PMVP annual working capital is now -54.99% below its all-time high of $358.35 million, reached on December 31, 2020.
Performance
PMVP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$161.29 M
-$14.77 M-8.39%
December 31, 2024
Summary
- As of March 5, 2025, PMVP quarterly working capital is $161.29 million, with the most recent change of -$14.77 million (-8.39%) on December 31, 2024.
- Over the past year, PMVP quarterly working capital has dropped by -$14.77 million (-8.39%).
- PMVP quarterly working capital is now -56.20% below its all-time high of $368.20 million, reached on September 30, 2020.
Performance
PMVP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PMVP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.6% | -8.4% |
| 3 y3 years | -44.2% | -17.1% |
| 5 y5 years | +65.3% | -17.1% |
PMVP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.2% | at low | -44.2% | at low |
| 5 y | 5-year | -55.0% | +65.3% | -56.2% | +65.3% |
| alltime | all time | -55.0% | +169.2% | -56.2% | +65.3% |
PMV Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $161.29 M(-16.6%) | $161.29 M(-8.4%) |
| Sep 2024 | - | $176.06 M(-15.1%) |
| Jun 2024 | - | $207.40 M(+8.9%) |
| Mar 2024 | - | $190.40 M(-1.5%) |
| Dec 2023 | $193.38 M(-18.1%) | $193.38 M(-0.6%) |
| Sep 2023 | - | $194.58 M(+8.7%) |
| Jun 2023 | - | $178.97 M(-19.6%) |
| Mar 2023 | - | $222.69 M(-5.7%) |
| Dec 2022 | $236.17 M | $236.17 M(-6.8%) |
| Sep 2022 | - | $253.52 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $270.48 M(-2.1%) |
| Mar 2022 | - | $276.36 M(-4.4%) |
| Dec 2021 | $289.07 M(-19.3%) | $289.07 M(-5.2%) |
| Sep 2021 | - | $304.99 M(-3.4%) |
| Jun 2021 | - | $315.58 M(-4.1%) |
| Mar 2021 | - | $329.16 M(-8.1%) |
| Dec 2020 | $358.35 M(+267.3%) | $358.35 M(-2.7%) |
| Sep 2020 | - | $368.20 M(+142.7%) |
| Jun 2020 | - | $151.70 M(+55.5%) |
| Dec 2019 | $97.57 M(+62.9%) | $97.57 M |
| Dec 2018 | $59.91 M | - |
FAQ
- What is PMV Pharmaceuticals annual working capital?
- What is the all time high annual working capital for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual working capital year-on-year change?
- What is PMV Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly working capital year-on-year change?
What is PMV Pharmaceuticals annual working capital?
The current annual working capital of PMVP is $161.29 M
What is the all time high annual working capital for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual working capital is $358.35 M
What is PMV Pharmaceuticals annual working capital year-on-year change?
Over the past year, PMVP annual working capital has changed by -$32.09 M (-16.60%)
What is PMV Pharmaceuticals quarterly working capital?
The current quarterly working capital of PMVP is $161.29 M
What is the all time high quarterly working capital for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly working capital is $368.20 M
What is PMV Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, PMVP quarterly working capital has changed by -$14.77 M (-8.39%)